Breast Cancer Siblings Database
RATIONALE: Collecting blood samples and health information from patients with invasive breast cancer and from their brothers and sisters over time may help the study of cancer in the future.
PURPOSE: This study is collecting blood samples and health information over time from patients with invasive breast cancer and from their brothers and sisters.
Description
OBJECTIVES:
- Collect blood samples and medical and background information from patients with invasive breast cancer and their affected or unaffected siblings.
OUTLINE: Patients and their siblings undergo blood collection. They also complete medical and background questionnaires.
Patients and their siblings are followed annually for 5 years.
PROJECTED ACCRUAL: A total of 1,000 patients and siblings will be accrued for this study.
Status: Recruiting (N/A). Started on January 1st, 2001.
Enrollment: 1000 subjects
Study Type: Observational
Study Design:
- N/A
Conditions:
Interventions:
- Other: biologic sample preservation procedure
- Other: informational intervention
Eligibility
DISEASE CHARACTERISTICS:
Meets 1 of the following criteria:
Pathologically confirmed invasive breast cancer (patient)
No ductal carcinoma in situ
Affected OR unaffected sibling
Affected sibling must have had (or currently has) breast cancer only
Unaffected sibling must be female
No deceased siblings
Must be a full-blood related sibling
Patients receiving treatment on clinical trial ECOG-E1Y97 or ECOG-E3Y92 are not eligible
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
- Gender
Both
- Mininum Age
18 Years
- Maximum Age
N/A
- Healthy Volunteers
Accepts Healthy Volunteers
Resources
Source: National Cancer Institute (NCI)
Authority: Unspecified
Locations
-
GenBasix Incorporated
Duarte
California
91010
United States
Officials
Richard A. Shapiro, MD (Study Chair, GenBasix Incorporated)
Sponsors
GenBasix Incorporated (Lead Sponsor)
References
None.
Links
- Date Verified
- July 1st, 2009
- First Received
- November 5th, 2010
- Last Changed
- November 5th, 2010
Information obtained from ClinicalTrials.gov on June 09, 2011. Link to the current ClinicalTrials.gov record.
All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.
The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.